applicability

Related by string. Applicability * * broad applicability . Applicability Statement . universal applicability *

Related by context. All words. (Click for frequent words.) 54 inapplicability 54 scope 54 validity 51 patentability 50 nonobviousness 49 usefulness 49 extraterritorial application 49 applicable 49 claim preclusion 49 caselaw 49 patentable subject 48 FAA preempts 48 permissibility 48 relevance 48 presumptively valid 48 precedential value 47 overbreadth 47 Rev. Rul 47 § #-#-# [006] 47 severability 47 separability 47 Construing 47 enforceability 47 inapplicable 47 generalisability 47 habeas statute 46 effectiveness 46 generalizability 46 justiciability 46 construing 46 arbitrability 46 practicability 46 nonprecedential 46 judicial estoppel 46 efficacy 46 applies 46 implications 46 NJSA 2A #A 45 constitutes patentable 45 patentable invention 45 vires 45 reviewed de novo 45 taxability 45 Younger abstention 45 acceptability 45 Sialic Switch technology 45 facially unconstitutional 45 reasonableness 44 Applicability 44 NYCHRL 44 overbreadth doctrine 44 tenability 44 KSR Int'l Co. 44 OCGA § #-#-#.# 44 presumptively invalid 44 retroactivity 44 constitutionality 44 construed liberally 44 unconscionability 44 therapeutic equivalence 44 expressly preempted 44 § #-#-# [002] 44 Arbitration Procedure 44 Collateral estoppel 44 w ithout 43 legality 43 arbitrable 43 GL c 43 Appellants contend 43 IRTPA 43 coram nobis 43 purposive interpretation 43 apply extraterritorially 43 broad applicability 43 #CFR# 43 unpatentability 43 issue preclusion 43 v. Teleflex Inc. 43 transferability 43 inferential statistics 43 patentable inventions 43 purposeful availment 43 § #-#.# [003] 43 predictive validity 43 Eminent Domain Procedure 43 interpretation 43 Vaxfectin R 42 divisibility 42 Declaratory Judgment Act 42 preemption 42 Proximate cause 42 preemption clause 42 penal statutes 42 proximate causation 42 dispositive procedural ruling 42 § #.# [003] 42 lawfulness 42 patent invalidity 42 replicability 42 non derogable 42 exculpatory clauses 42 Sepracor patents 42 equitable tolling 42 divergent interpretations 42 subsection d 42 section #A.# [002] 42 '# patent invalid 42 vacatur 42 liberally construe 42 substantive unreasonableness 42 pari materia 42 Rule #:#-# [001] 42 jurisdictional prerequisite 42 CFR § #.# [007] 42 precedential 42 unpatentable 42 #.#A [001] 42 PKC isozymes 42 preclusive effect 42 Restatement Second 42 uncodified 42 Equitable tolling 42 § #-#-# c [001] 42 impermissibly retroactive 41 impermissibly vague 41 unpatentable abstract idea 41 expressly preempts 41 unius est 41 manifest disregard 41 numerosity 41 '# patents 41 C ourts 41 CFR § #.# [006] 41 w hether 41 disapply 41 extraterritoriality 41 Dicer Substrate Technology 41 obviousness 41 appropriateness 41 substantive unconscionability 41 heterogeneity 41 s.# [001] 41 NJRE 41 KRS #.# [003] 41 Civil Procedure Rule 41 preclusion 41 substitutability 41 coextensive 41 specificity 41 u nless 41 foreseeability 41 procedural reasonableness 41 factual underpinnings 41 moral rightness 41 granted certiorari 41 Defendant asserts 41 § #.# [006] 41 equitable estoppel 41 CFR § #.# [005] 41 permissible 41 AEDPA statute 41 mootness 41 convergent validity 41 Reproducibility 41 § #-#-# b [002] 41 La. RS #:# [002] 41 pertinence 41 factual predicate 41 purposive approach 41 Suspension Clause 41 subparts 41 CMOS scaling 41 Norwich Pharmacal 41 peremptory norm 41 personal blog Screenwerk 41 expressly disavowed 40 prosecution laches 40 § #B#.# [002] 40 dispositive motions 40 summarily affirm 40 TRIPS compliant 40 substantively unconscionable 40 nonstatutory 40 finite element modeling 40 arbitral tribunals 40 § #.# [002] 40 definitions 40 construing statute 40 noninfringement 40 § #A [002] 40 dormant Commerce Clause 40 Öko Institut 40 KRS #.#-# 40 vitro dissolution 40 typicality 40 CFR § #.# [001] 40 Implementing Regulations 40 facially invalid 40 § #-#-# [003] 40 exceptionality 40 contexts 40 #A.# [006] 40 #.#A [005] 40 Dormant Commerce Clause 40 § #-# [003] 40 patentable 40 ERISA preempts 40 g enerally 40 Judgments § 40 maintainability 40 obviousness rejection 40 presumptively reasonable 40 pari delicto 40 NJSA #:#-# [004] 40 anticircumvention 40 WARF stem cell 40 photoselective 40 physicochemical characteristics 40 Wyo. Stat 40 Ontario v. Quon 40 bsent 40 compensability 40 Hofsheier 40 PS § 40 compulsory counterclaim 40 BPAI 40 Free Exercise Clause 40 jurisdiction 40 WAC #-#-# 40 HRS § #-# [002] 40 Wis. Stat 40 prohibits outrages 40 § 7A 40 non justiciable 40 admiralty jurisdiction 40 precluded summary judgment 40 REACH RoHS 40 patentably distinct 40 Rent Stabilization Code 40 AEDPA 40 CSR #-#.# 40 microeconomic theory 40 allowability 40 descriptiveness 40 scienter requirement 40 affordances 40 ARS § 40 Codifying 40 presumptively unconstitutional 40 judicially enforceable 40 Spreigl evidence 40 collaterally attack 40 Article XIII 40 Colo. Sess 40 EDNY 40 invariants 40 Hemopurifier ® 40 molecular nanotechnology MNT 40 percepts 40 § #a [002] 40 § #-# [001] 40 La.Civ.Code art 40 String theory 40 CFR § 40 ambit 40 misapprehends 40 interlocutory appeals 40 f ederal 39 sequence homology 39 validity enforceability 39 ResQNet 39 Rooker Feldman 39 Supp. 39 #.# 5T 39 Kentucky Revised Statutes 39 c ounsel 39 Applying 39 Constitutionality 39 indefiniteness 39 DC Code § 39 Vertical Restraints 39 LSA RS #:# [002] 39 communicability 39 nonconstitutional 39 dissimilarity 39 Appellant asserts 39 nominative fair 39 lymphatic mapping 39 § #A [003] 39 s uch 39 perturbation theory 39 empirically testable 39 § #.# [004] 39 materiality 39 Animal Efficacy 39 Anti Kickback 39 mathematical formalism 39 FSIA 39 discriminant validity 39 § #b [002] 39 definitional 39 Subsection c 39 interpretability 39 Ex Post Facto 39 Appellate Division affirmed 39 unconstitutionality 39 standardless 39 interchangeability 39 Wickard v. Filburn 39 equitable mootness 39 misapplies 39 reh'g denied 39 procedurally barred 39 para. 39 PAJA 39 b ased 39 argument unpersuasive 39 limitations 39 JMOL 39 genotoxicity 39 pertains 39 intendment 39 postconviction proceedings 39 APTIMA HPV assay 39 NJSA #:#-# [002] 39 CFR § #.# [004] 39 Limitations 39 centrality 39 visitorial powers 39 IC § 39 Vaxfectin R adjuvant 39 inheres 39 setoffs 39 NJSA #A #A 39 justiciable 39 § § #-#-# [001] 39 constitutionally delegated 39 promulgated pursuant 39 Civil Procedure 39 facially neutral 39 § #A.# 39 simpliciter 39 glycosylation pattern 39 ll.# 39 conformance 39 FRAND 39 RA# [003] 39 Subpart F 39 restitutionary 39 Eleventh Circuits 39 forum non conveniens 39 apply 39 § #-#.# [002] 39 DOHSA 39 factual determinations 39 pharmacodynamic markers 39 #.# subds [001] 39 causation 39 La.RS #:# [003] 39 b Vernon Supp 39 Restatement § 39 relitigated 39 Competitive Impact Statement 39 #:#-#.# 39 #.#-# [005] 39 reh'g 39 pertaining 39 Rule #:#-# b 39 fluctuating workweek 39 adjuvant therapies 39 S uch 39 suitability 39 presumptively unreasonable 39 construal 39 Tax Injunction 39 KSR v. Teleflex 39 methodologic 39 contractual indemnity 39 preclude summary judgment 39 Bayesian statistical 39 conclusiveness 39 SOX whistleblower 39 § #.#-# [004] 39 § #-#-# [004] 39 UKIPO 39 Rule #:#-# [002] 39 rebuttable presumptions 39 jus cogens 39 merits 39 misapplied 39 Torts § 39 TRIPs Agreement 38 Codified 38 International v. Teleflex 38 intellectualproperty 38 § #.#-# et seq 38 GRAVITAS trial 38 Directive #/#/EC amending 38 RC #.# B [002] 38 § #-# [002] 38 ratemaking principles 38 § #C#.# 38 invariance 38 § #-#-# [001] 38 4th DCA 38 § #.#-# [001] 38 Interrogatory No. 38 protein tyrosine phosphatases 38 limitation 38 NDCC ch 38 Tenth Circuit 38 Exercising jurisdiction 38 certiorari 38 La.RS #:#.# [001] 38 dispositive motion 38 CRCP 38 proportionality 38 liberally construed 38 justiciable controversy 38 LSA RS #:# [001] 38 strictly construe 38 FOIA exemption 38 al Odah v. 38 See Restatement Second 38 methodological weaknesses 38 interlocutory orders 38 sua sponte dismissal 38 CFR #.# [008] 38 judicially manageable 38 Judge Scheindlin 38 etiology 38 preclinical efficacy 38 § #.# [001] 38 empirical observation 38 severability provision 38 Va. Code § 38 statutorily prescribed 38 § #.#.# [002] 38 #B.# [001] 38 s#A [002] 38 universal applicability 38 reversibility 38 Obviousness 38 copyleft licenses 38 UNCITRAL Model Law 38 § #-#-# [005] 38 legally protectable 38 GLc 38 contravenes Article 38 Interchangeability 38 capacitance voltage 38 preempts 38 gross disproportionality 38 TCA § #-#-# [003] 38 OCGA § #-#-# [007] 38 sub ject 38 Eleventh Amendment 38 COGSA 38 Bayes theorem 38 Enforceability 38 CB1 antagonists 38 sensitivity specificity 38 factual sufficiency 38 unmeasured confounding 38 epistemology 38 Act RFRA 38 APTIMA HPV 38 re quirements 38 Cal. Rules 38 LEXIS 38 habeas stripping 38 Res judicata 38 Prof. Rabani 38 circumscribing 38 CUTPA 38 Nanomedicine Nanomedicine 38 WARF patents 38 vagueness 38 Eleventh Circuit 38 vivo potency 38 jus ad bellum 38 Code Sec 38 Turner v. Safley 38 CFR #.# [007] 38 CFR § #.# [002] 38 nanotoxicology 38 generis 38 contextualisation 38 Bioavailability 38 endophenotypes 38 NJSA #:# [002] 38 CFR § #.# [003] 38 ORS #A.# 38 Treatment Protocols 38 Regulations CFR 38 Applicable 38 Proprietary algorithms 38 Bayesian inference 38 PCI Express motherboards 38 generalizable 38 chemosensitivity 38 Okla. Stat 38 Ninth Circuit affirmed 38 presumptively lawful 38 Anti Avoidance 38 colorable 38 admissibility 38 ITEPA 38 cmt 38 hereby DENIED 38 overbroad 38 iPCS exclusivity 38 nonjurisdictional 38 parol evidence 38 ToleroMune 38 MDDS 38 Sentencing Guidelines Manual 38 Confirms Validity 38 noninfringing uses 38 ex turpi causa 38 subsections b 38 RSMo 38 u pon 38 Rooker Feldman doctrine 38 SLUSA 38 punctuation omitted 38 DMEPOS supplier 38 antiretaliation provision 38 obiter 38 justifiability 38 FRCP amendments 38 n.1 38 inventorship 38 #.# subd [006] 38 rigorously analyzes 38 interjurisdictional immunity 38 pharmacogenetic testing 38 factual predicates 37 ascertainable 37 stochastic optimization 37 n otwithstanding 37 Markman Order 37 SEBI Takeover Code 37 CRS #-#-# [002] 37 IEC #-# [001] 37 Dismiss Plaintiff 37 Code Civ 37 maqasid 37 Uniform Arbitration 37 MGL c 37 w hile 37 therapeutic radiopharmaceuticals 37 potent antitumor activity 37 Guidance Document 37 Daniel Rotrosen MD 37 RFE SVM 37 quantum correlations 37 soluble CD# 37 noninferiority 37 IgG1 antibodies 37 section #.#b 37 JUSTICE STEVENS 37 metabolomic profiling 37 speci c 37 Rev. Proc 37 NJSA #:#-#.# [001] 37 Informed consent 37 protein ligand interactions 37 pleadings liberally 37 Seventh Circuit 37 periprocedural MI 37 § #.#.# [001] 37 instantiations 37 jurisdication 37 infeasibility 37 Noerr Pennington doctrine 37 tumor oxygenation 37 magnon 37 nonappealable 37 n.4 37 TrAIL Co. 37 n.6 37 IRC § 37 gatekeeping function 37 nonstandardized 37 mandamus proceeding 37 semantic interoperability 37 Internal Revenue Code § 37 tolerability pharmacokinetics 37 linewidth 37 lthough 37 § #-#-# b [001] 37 genomic biomarkers 37 Faragher Ellerth defense 37 Hague Visby Rules 37 Vaxfectin TM adjuvant 37 Due Process Clause 37 substantive reasonableness 37 Time Warp patent 37 retrospective observational 37 ofsuch 37 FMIA 37 waive sovereign immunity 37 PCI DSS FISMA HIPAA 37 CAFA jurisdiction 37 § #c 37 sua sponte duty 37 DFAR 37 #.# subdivision [004] 37 econometric techniques 37 La.Code Crim.P. art 37 IntroductionThe 37 electron proton 37 homologies 37 readily comprehensible 37 NRS #.# [003] 37 appealability 37 KSA #-# [001] 37 u nder 37 inhere 37 irrevocability 37 § #-#-# c [002] 37 patentee 37 xxxi adverse tax 37 Lord Mance 37 section #-#-# [002] 37 nonobvious 37 ICAO Annex 37 NCGS § 37 enzyme kinetics 37 Minn. Stat 37 invalidity 37 EOBR mandate 37 lenity 37 § #-# [004] 37 Summary Judgment Order 37 Code § #-#.# 37 section #.#.# 37 commercialize axon regeneration 37 VeraTag assays 37 VDAs 37 EU RoHS Directive 37 ZapMedia applied 37 spectrum antibiotic 37 SDWA 37 Title VII retaliation 37 Materiality 37 ALN RSV program 37 ultra vires 37 Slip op 37 psychometrically sound 37 Appellants argue 37 competitively procured pursuant 37 non infringement invalidity 37 CERCLA liability 37 Section #AB 37 Uniformity Clause 37 § § 37 Dyax phage display 37 impermissibly infringe 37 § 37 affirmance 37 vagueness doctrine 37 ZHB 37 Procedure Code 37 RCW #.#A.# 37 Assisted reproductive 37 particle morphology 37 Section #-#-# [006] 37 COMI 37 Contracts § 37 Ala. R. Civ 37 immunotherapeutic approaches 37 Mechanistic 37 Ex parte Young 37 Concession Arrangements 37 adoptability 37 causal inference 37 NJSA #:#-#.# [002] 37 e ach 37 totalisation 37 Director Jon Dudas 37 Part IIIA 37 interpretational 37 ramifications 37 radiation dosimetry 37 § #A [001] 37 estoppel 37 significance 37 prejudice prong 37 Johnson v. Eisentrager 37 pharmacodynamic parameters 37 construes 37 discriminant 37 hESC derived cells 37 verity 37 § § #-# [001] 37 PL #-# [002] 37 extraterritorial 37 p# INK4a 37 narrowly circumscribed 37 p rior 37 interlinkages 37 OCABR 37 Section #-#-# [004] 37 subsection h 37 Systematic reviews 37 CFR #.# [001] 37 RFCMOS HV CMOS 37 Mutual Funds Regulations 37 Undisputed Facts 37 Imposing Lawyer 37 preliminary injunctive relief 37 equitable subordination 37 W ithout 37 voluntariness 37 serum biomarkers 37 Civil Procedure Sec 37 Zubulake v. UBS Warburg 37 certif 37 Alequel ™ 37 xxxi 37 elementary particle physics 37 impracticability 37 withrespect 37 La.Code Civ.P. art 37 SLHCs 37 factually distinguishable 37 § #B 37 antigen identification 37 NGPA 37 encompass 37 antiplatelet therapies 37 calorimetric 37 computational complexity 37 Hyperspectral imaging 37 See USSG 37 ISO IEC JTC1 37 habeas petitioner 36 disaggregates 36 extrinsic evidence 36 section #A.# [001] 36 NJSA #:#-#.# [003] 36 nonbankruptcy 36 methodologically rigorous 36 NPRM proposes 36 TechNavio Insights highlights 36 '# patent 36 jurisprudence 36 complimentarity 36 Gen. Stat 36 USCA § 36 n othing 36 END FOOTNOTE FOOTNOTE 36 CFR #.# c 36 #A.# [005] 36 2d Cir.# 36 controverting 36 Selectivity 36 antiviral efficacy 36 Elias Zacarias 36 dispositive 36 de minimis exception 36 amaZon 36 Linux infringes 36 construing statutes 36 Procurement Integrity 36 Riegel v. 36 applicational 36 hereby GRANTED 36 KRAS mutation status 36 realizability 36 creates rebuttable presumption 36 KSA #-# b 36 unconstitutionally infringed 36 adjudicative functions 36 efficacies 36 posttrial 36 quantum chromodynamics QCD 36 interobserver agreement 36 Section #-#-# [005] 36 Latent Semantic Analysis 36 extra territoriality 36 construe 36 renders obsolete Geneva 36 applies retroactively 36 SIMD extensions 36 HB# Provides [002] 36 DDS middleware 36 geographical dispersion 36 context 36 KSA #-# d 36 quoting Restatement Second 36 Hazardous Materials Regulations 36 inherently subjective 36 Fully conversant 36 § #-#-# [008] 36 forborne 36 methodological individualism 36 Correlative 36 nanoscale phenomena 36 probabilistic reasoning 36 g iven 36 SEC Rule #g# 36 adequately pled 36 stochastic simulation 36 topical anti infectives 36 res judicata 36 analogical reasoning 36 synthetic genomics 36 CAFC reversed 36 blatant contravention 36 exculpatory clause 36 Conforms 36 robustness 36 Non Discriminatory 36 Section #I 36 Octreolin 36 Validity 36 ore tenus 36 elicitation 36 contributory infringement 36 inter partes reexamination 36 Heterogeneity 36 neuroanatomical 36 novel therapeutic modality 36 ecotoxicological 36 dicta 36 Symetron TM technology 36 stereochemical 36 RTCA DO #B 36 collateral estoppel 36 Notice #-# [001] 36 physicochemical properties 36 RCr #.# 36 repugnancy 36 analgesic efficacy 36 extent 36 CVT E# 36 La. Code Civ 36 cognizable 36 CrR #.# 36 Mississippi Tort Claims 36 antitumor effect 36 § #a [003] 36 USC § #a [001] 36 PFICs 36 immunostimulatory effects 36 Judge Luckern 36 powder diffraction 36 counterclaims asserted 36 explicitly exempts 36 Skousen devotees 36 Coronary CTA 36 La. RS #:# [001] 36 cardioprotective effects 36 biodistribution 36 ShearWave Elastography 36 Amending Directive 36 exportability 36 PGxPredict 36 Apprendi 36 CEQA Guidelines 36 Subsection b 36 universality 36 CellScan 36 rPA vaccine candidate 36 viral kinetics 36 computability 36 s.# [002] 36 imposition 36 Tennessee Code Annotated 36 tPEMF tm 36 Modvat 36 liquid chromatographic 36 Du Frane 36 dosimetric 36 Bilski patent 36 § #E 36 CPT coding 36 lodestar method 36 Penalty Guidelines 36 #A.# [004] 36 thereby precluding 36 R. #:#-# 36 OFPA 36 particularity requirement 36 diffusion coefficients 36 Standardising 36 Docket # 36 s ection 36 scientific substantiation 36 Article XIX 36 Plaintiff Complaint 36 interpreting 36 enforced inconsistently 36 intraobserver 36 ReCyte 36 rendered ineffectual 36 electromechanical coupling 36 CFR § § 36 JNOV motion 36 metabonomics 36 evident partiality 36 § #e 36 nonsignatory 36 combinability 36 Alien Tort 36 appealable interlocutory 36 Fundamental fairness 36 co receptor tropism 36 Langes + 36 summary judgment de novo 36 viral tropism 36 raisons d' être 36 section #-#-# [003] 36 merely codifies 36 applies prospectively 36 People v. Doganiere 36 quantum phenomena 36 plaintiffs appellees 36 parasitological 36 falsifiability 36 fusion enhancers 36 Complementarity 36 distributing misbranded 36 Aplt 36 xxxiii 36 FAR clauses 36 ERISA pre empts 36 n.3 36 Issue preclusion 36 VSA § 36 logical positivism 36 procedurally defaulted 36 Flast 36 arguable merit 36 MEJA 36 aCRM 36 noncardiac chest pain 36 irrebuttable 36 adjudicating disputes 36 MHPAEA 36 Bankruptcy Procedure 36 Current Procedural Terminology 36 ACCESS NetFront browser 36 untimeliness 36 CFR § #.# [008] 36 Patentees 36 judicially reviewable 36 nontestimonial 36 section #AA 36 antidepressant efficacy 36 conceptual frameworks 36 inter partes 36 pervasiveness 36 Corpus Juris 36 DSM IV diagnoses 36 Cronbach alpha 36 multifunctionality 36 contemporary operatic repertoire 36 habeas relief 36 Judicature Act 36 Hamdi v. 36 derogating 36 Doha Ministerial Declaration 36 fundamental precept 36 MassARRAY platform 36 AlloMap testing 36 Wechsler Memory 35 Utility MACT 35 non discriminatory FRAND 35 coatings inks 35 Title VII disparate 35 EP# [001] 35 Kinesia 35 Serializer Deserializer SerDes 35 tolerancing 35 readily adaptable 35 State ex rel 35 OSAs 35 varietyof 35 methodological rigor 35 Double Jeopardy Clause 35 BAPCPA 35 confirmatory clinical 35 Fla. 2d DCA 35 manifestly disregarded 35 MSCRAMM 35 ICNIRP 35 Subparagraph 35 Jury Instruction 35 Kei Utsugi researcher 35 impliedly 35 subparagraph b 35 hardware software webware 35 subpart 35 pharmacokinetic equivalence 35 FD SOI

Back to home page